The Veteran's prostate cancer residuals are rated at a 40 percent rating since September 16, 2022. The appeal for a higher rating is denied. SMC under 38 U.S.C. § 1114(s) from January 1, 2019 is also denied.
The deciding factor: The Veteran's prostate cancer residuals have been consistently rated at 40 percent since September 16, 2022 due to voiding dysfunction and urinary frequency issues. The evidence does not support a higher rating or SMC under 38 U.S.C. § 1114(s).
- Claimed conditions
- Prostate cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 28, 2022
- Citation
- 22066200
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 22066200.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's arteriosclerotic heart disease is rated at 100% effective October 25, 2024. His prostate cancer residuals are rated at 60% effective October 25, 2024.
- Whole decision: Granted
The Veteran's acquired psychiatric disorder and prostate cancer are granted service connection, with the latter requiring a VA examination to address exposure to burn pits.
- Whole decision: Denied
The Veteran's claim for service connection for hearing loss in the right ear has been denied. The Board found that there is no current diagnosis of right ear hearing loss and thus, cannot establish a link to service. For prostate cancer, the Veteran's claim is remanded as VA did not provide an opinion regarding whether his condition may be related to service due to toxic exposure.
- Whole decision: Denied
The Veteran's prostate cancer residuals prior to January 5, 2026 are rated at 10 percent. From January 5, 2026, the Veteran is granted a 20 percent rating for his prostate cancer residuals. The Veteran's left ear hearing loss is not compensable.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.